Atara Biotherapeutics, Inc.·4

Feb 19, 8:53 PM ET

Yarema Kristin 4

4 · Atara Biotherapeutics, Inc. · Filed Feb 19, 2020

Insider Transaction Report

Form 4
Period: 2020-02-18
Yarema Kristin
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2020-02-18+110,000110,000 total
    Exercise: $14.56Exp: 2030-02-17Common Stock (110,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on February 18, 2021 and the remaining shares vest in equal monthly installments over the following 36 months.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION